Found: 17
Select item for more details and to access through your institution.
Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivity.
- Published in:
- Journal of Asthma & Allergy, 2013, v. 6, p. 81, doi. 10.2147/JAA.S42695
- By:
- Publication type:
- Article
Symptomatic Effects of Exposure to Diluted Air Sampled from a Swine Confinement Atmosphere on Healthy Human Subjects.
- Published in:
- Environmental Health Perspectives, 2005, v. 113, n. 5, p. 567, doi. 10.1289/ehp.6814
- By:
- Publication type:
- Article
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 2, p. 1, doi. 10.1186/ar4500
- By:
- Publication type:
- Article
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 2, p. 1, doi. 10.1186/ar4497
- By:
- Publication type:
- Article
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 5, p. 1, doi. 10.1186/ar4318
- By:
- Publication type:
- Article
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
- Published in:
- 2021
- By:
- Publication type:
- journal article
086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
The Clinical and Environmental Determinants of Airway Transcriptional Profiles in Allergic Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 6, p. 620, doi. 10.1164/rccm.201108-1503OC
- By:
- Publication type:
- Article
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 10, p. 2557, doi. 10.1002/art.39254
- By:
- Publication type:
- Article
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 2, p. 273, doi. 10.1093/mr/roab021
- By:
- Publication type:
- Article
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030
- By:
- Publication type:
- Article
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 1, p. 59, doi. 10.1080/14397595.2020.1859675
- By:
- Publication type:
- Article
Pegloticase and Chronic Gout.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 7, p. 711, doi. 10.1001/jama.2011.1169
- By:
- Publication type:
- Article
Safety of incremental inhaled lipopolysaccharide challenge in humans.
- Published in:
- Innate Immunity, 2006, v. 12, n. 2, p. 113, doi. 10.1177/09680519060120020701
- By:
- Publication type:
- Article